The Complete Darvocet (Propoxyphene/Acetaminophen) Buying Guide

What Was Darvocet?

Darvocet was a combination medication containing propoxyphene napsylate (a weak opioid analgesic) and acetaminophen (a non-opioid pain reliever). It was one of the most widely prescribed pain medications in the United States before its withdrawal.

Propoxyphene was first synthesized in 1955 and approved by the FDA in 1957. It was marketed under several brand names, including Darvocet, Darvon, and Darvocet-N. Darvocet combined propoxyphene with acetaminophen for enhanced pain relief.

Darvocet was designated as a Schedule IV controlled substance under the federal Controlled Substances Act. It was withdrawn from the US market in November 2010 due to cardiac safety concerns.

How Darvocet Worked

Propoxyphene worked as a weak mu-opioid receptor agonist, similar in structure and mechanism to methadone. It produced analgesia by binding to opioid receptors in the central nervous system, reducing the perception of pain.

The acetaminophen component provided additional pain relief through its own analgesic mechanisms (prostaglandin synthesis inhibition in the CNS). The combination was thought to provide synergistic pain relief.

Propoxyphene was considered a weak opioid, with analgesic potency approximately 50% that of morphine. It was commonly prescribed for mild to moderate pain, such as dental pain, postoperative pain, and musculoskeletal pain.

Former FDA Schedule & Classification

Former FDA-Approved Uses

Darvocet was FDA-approved for the management of mild to moderate pain:

• Postoperative pain: Mild to moderate pain following surgical procedures
• Dental pain: Pain following dental procedures
• Musculoskeletal pain: Back pain, sprains, strains
• Headache: Tension-type and other mild headaches

Darvocet was intended for short-term use due to the risk of tolerance, dependence, and withdrawal. It was one of the most commonly prescribed opioid analgesics in the US before its withdrawal.

Why Darvocet Was Withdrawn

The primary reason for withdrawal was new data showing that propoxyphene caused serious and potentially fatal cardiac rhythm abnormalities, specifically QT prolongation. Even at therapeutic doses, propoxyphene could cause fatal cardiac arrhythmias.

The FDA concluded that the cardiac risks of propoxyphene outweighed its benefits as a pain reliever, particularly because other effective pain medications with better safety profiles were available.

Cardiac Toxicity & QT Prolongation

The key safety concern with propoxyphene was its ability to cause QT prolongation, a dangerous change in the heart's electrical activity that can lead to a potentially fatal heart rhythm called torsades de pointes.

• QT prolongation: Propoxyphene was shown to prolong the QT interval on electrocardiogram (ECG), even at therapeutic doses
• Torsades de pointes: A specific type of ventricular tachycardia that can occur with QT prolongation and may degenerate into ventricular fibrillation and cardiac arrest
• Dose-dependent risk: The risk of QT prolongation increased with higher doses and in patients with risk factors (electrolyte abnormalities, liver disease, heart disease)
• Post-marketing reports: Reports of cardiac arrest and sudden death in patients taking propoxyphene prompted the investigation that led to withdrawal
• Metabolite toxicity: Norpropoxyphene, the active metabolite, also has cardiotoxic properties and accumulates with repeated dosing and in renal impairment

The FDA's decision was based on new studies demonstrating that propoxyphene, even when taken as directed, could cause fatal cardiac arrhythmias. The risk was deemed too great when safer alternatives existed for the same indications.

What If You Previously Took Darvocet?

If you previously took Darvocet and are concerned about its effects, here is what you should know:

• No ongoing cardiac effects: Propoxyphene is not stored in the body. Any cardiac effects from past use would have resolved after discontinuation.
• Consult your healthcare provider: If you have concerns about past propoxyphene use, especially if you experienced cardiac events, discuss this with your doctor.
• Current pain management options: There are many effective and safer alternatives for mild to moderate pain. Consult your provider about appropriate alternatives.
• Avoid illegal products: Some unregulated products may illegally contain propoxyphene. These products pose serious health risks and should be avoided.
• Cardiac screening: If you took propoxyphene for an extended period and have concerns about cardiac effects, discuss this with your healthcare provider.